Ascentage Pharma Group In...

NASDAQ: AAPG · Real-Time Price · USD
49.15
1.95 (4.13%)
At close: Aug 21, 2025, 3:58 PM
48.57
-1.18%
After-hours: Aug 21, 2025, 06:07 PM EDT

Ascentage Pharma International Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Cash & Equivalents
1.24B 1.1B 1.07B 1.58B 1.48B 1.7B 1.71B 1.1B
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a 428.7M
Long-Term Investments
33.86M n/a 18.95M n/a 18.53M n/a n/a n/a
Other Long-Term Assets
59M 52.5M 10.05M 368.64M 361.93M 38.84M 63.73M 105.05M
Receivables
99.07M 852.81M 163.54M 174.22M 61.49M 161.5M 54.13M 66.34M
Inventory
6.6M 10.72M 16.17M 5.02M 9.45M 5.25M 3.93M n/a
Other Current Assets
24.63M n/a 24.54M n/a 16.6M -80.83M 59.26M -56M
Total Current Assets
1.47B 1.96B 1.34B 1.76B 1.64B 1.87B 1.89B 1.6B
Property-Plant & Equipment
905.86M 931.18M 957.23M 633.06M 650.02M 968.46M 854.3M 616.64M
Goodwill & Intangibles
100.69M 104.47M 110.14M 104.8M 109M 115.53M 85.11M 88.47M
Total Long-Term Assets
1.14B 1.14B 1.16B 1.16B 1.19B 1.17B 1.05B 810.15M
Total Assets
2.62B 3.11B 2.5B 2.92B 2.83B 3.03B 2.94B 2.41B
Account Payables
91.97M 83.08M 72.44M 47.72M 95.56M 85.73M 70.86M 28.4M
Deferred Revenue
54.09M n/a 38.41M n/a 24.35M n/a n/a n/a
Short-Term Debt
769.62M 720.1M 606.65M 396M 510.31M 298.93M 39.8M 23.95M
Other Current Liabilities
n/a 37.48M n/a 24.35M 2.82M 30M 58.73M 25K
Total Current Liabilities
1.17B 1.07B 934.17M 642.88M 881.15M 612.3M 361.11M 193.79M
Long-Term Debt
868.64M 959.14M 1.17B 1.26B 1.27B 1.24B 1.03B 622.54M
Other Long-Term Liabilities
6.27M 18.8M 18.3M 185.31M 35.33M 52.63M 52.34M 75.97M
Total Long-Term Liabilities
1.18B 1.27B 1.5B 1.68B 1.54B 1.55B 1.34B 764.52M
Total Liabilities
2.34B 2.33B 2.43B 2.32B 2.42B 2.16B 1.71B 958.31M
Total Debt
1.67B 1.7B 1.8B 1.68B 1.79B 1.56B 1.08B 667.41M
Common Stock
214K 214K 197K 196K 180K 179K 178K 172K
Retained Earnings
-5.77B -5.2B -5.37B -4.84B -4.44B n/a -3.56B n/a
Comprehensive Income
-510.59M n/a -504.46M n/a -518.51M n/a n/a n/a
Shareholders Equity
264.19M 766.4M 60.42M 589.89M 408.66M 876.85M 1.23B 1.45B
Total Investments
33.86M 33.2M 18.95M 18.66M 18.53M 21.1M 27.84M 29.86M